The Cancer Letter

Inside information on cancer research and drug development

Vol.
28
No.
1
January 28, 2005Jan 28, 2005
Free
DOWNLOAD THE PDF

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

New Regimens May Benefit Multiple Myeloma Patients

Two New Modalities Promising For Relapsed/Refractory NHL

Amgen’s Kepivance Approved For Severe Oral Mucositis

Clolar Approved for Pediatric Refractory/Relapsed ALL

Blacks Half As Likely To Get Surgery For Esophageal Cancer

NCI-Approved Clinical Trials Listed For January

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account